What is the Catalyst Biosciences Inc stock price forecast?

Catalyst Biosciences Inc is currently trading at $18.17. View real-time AI analysis on Alpha Lenz.

What is Catalyst Biosciences Inc insider trading activity?

View the latest insider trading data for Catalyst Biosciences Inc on Alpha Lenz.

What is Catalyst Biosciences Inc's P/E ratio?

View Catalyst Biosciences Inc's valuation metrics on Alpha Lenz.

Catalyst Biosciences Inc

NASDAQ · CBIO

$18.17

Ask about Catalyst Biosciences Inc's future dividend policy...

Company Overview

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company is headquartered in Waltham, Massachusetts.

CEOMr. Joshua T. Brumm

Websitehttps://crescentbiopharma.com

SectorHealthcare

IndustryBiotechnology

Employees33

Company Statistics

FY 2024

Profile

N/AMarket Cap

N/ARevenue

0.00Shares Out

33Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

N/AROA

N/AROE

N/AROIC

Financial Health

$34.77MCash & Cash Equivalents

$16.33MNet Debt

-330.10%Debt/Equity

N/AInterest Cov

Frequently Asked Questions

Catalyst Biosciences Inc (ticker: CBIO) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 33 employees.

The current price is $18.17 with a P/E ratio of -x and P/B of -x.